Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and thymidine

rosiglitazone has been researched along with thymidine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo, T; Haraguchi, K; Hershman, JM; Ohta, K; Onaya, T1
Andò, S; Aquila, S; Bonofiglio, D; Catalano, S; Gabriele, S; Gentile, M; Giordano, F; Middea, E1
Amiri, F; Benkirane, K; Diep, QN; El Mabrouk, M; Schiffrin, EL1
Chou, FP; Lin, TM; Ou, HC; Sheu, WH; Yang, CH1
Bejjani, DE; Harrill, D; Hileman, C; McComsey, GA; O'riordan, MA; Rizk, N; Ross, AC; Storer, N; Tungsiripat, M1

Trials

1 trial(s) available for rosiglitazone and thymidine

ArticleYear
Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimens.
    AIDS (London, England), 2010, Jun-01, Volume: 24, Issue:9

    Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Cholesterol; Double-Blind Method; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; PPAR gamma; Reverse Transcriptase Inhibitors; Rosiglitazone; Thiazolidinediones; Thymidine

2010

Other Studies

4 other study(ies) available for rosiglitazone and thymidine

ArticleYear
Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Northern; Carcinoma, Papillary; Cell Division; Chromans; Humans; Male; Mice; Mice, Inbred BALB C; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Thymidine; Thyroid Neoplasms; Transcription Factors; Troglitazone; Tumor Cells, Cultured

2001
Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Sep-01, Volume: 11, Issue:17

    Topics: Breast Neoplasms; Cell Proliferation; Chromatin Immunoprecipitation; Electrophoretic Mobility Shift Assay; Estradiol; Estrogen Receptor alpha; HeLa Cells; Humans; Ligands; Phosphatidylinositol 3-Kinases; Phosphoric Monoester Hydrolases; Phosphorylation; PPAR gamma; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Signal Transduction; Thiazolidinediones; Thymidine; Transcription, Genetic; Transcriptional Activation; Tumor Suppressor Proteins; Vasodilator Agents

2005
PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Carrier Proteins; Cell Proliferation; Intracellular Signaling Peptides and Proteins; Leucine; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Phosphoproteins; Phosphoric Monoester Hydrolases; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Rosiglitazone; Signal Transduction; Thiazolidinediones; Thymidine

2006
Rosiglitazone inhibits endothelial proliferation and angiogenesis.
    Life sciences, 2006, Feb-23, Volume: 78, Issue:13

    Topics: Cell Division; Cell Survival; Cells, Cultured; DNA Replication; Endothelium, Vascular; Humans; Neovascularization, Pathologic; Rosiglitazone; Thiazolidinediones; Thymidine; Umbilical Veins; Vasodilator Agents

2006